We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
851
10x Genomics
TXG
$5.97B
– –
-14,000
Closed -$399K
VNO icon
852
Vornado Realty Trust
VNO
$7.54B
– –
-30,015
Closed -$695K
YMAB
853
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-172,584
Closed -$2.49M
Z icon
854
Zillow
Z
$7.7B
– –
-8,380
Closed -$240K
ITCI
855
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-35,907
Closed -$1.67M
MTTR
856
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
– –
-131,530
Closed -$499K
EVA
857
DELISTED
Enviva Inc.
EVA
– –
-90,871
Closed -$5.46M
HARP
858
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-79,269
Closed -$769K
COUP
859
DELISTED
Coupa Software Incorporated
COUP
– –
-6,543
Closed -$385K
ABMD
860
DELISTED
Abiomed Inc
ABMD
– –
-9,786
Closed -$2.4M
BTRS
861
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
– –
-378,497
Closed -$3.5M
SWCH
862
DELISTED
Switch, Inc. Class A Common Stock
SWCH
– –
-181,083
Closed -$6.1M
ZEN
863
DELISTED
ZENDESK INC
ZEN
– –
-112,612
Closed -$8.57M
AERI
864
DELISTED
Aerie Pharmaceuticals
AERI
– –
-142,745
Closed -$2.16M
ECOM
865
DELISTED
CHANNELADVISOR CORPORATION
ECOM
– –
-26,332
Closed -$597K
CYBE
866
DELISTED
Cyberoptics Corp
CYBE
– –
-91,392
Closed -$4.92M
TWTR
867
DELISTED
Twitter, Inc.
TWTR
– –
-185,402
Closed -$8.13M
CCXI
868
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-45,218
Closed -$2.34M
AVLR
869
DELISTED
Avalara, Inc.
AVLR
– –
-71,907
Closed -$6.6M
Y
870
DELISTED
Alleghany Corp
Y
– –
-3,733
Closed -$3.13M
FMTX
871
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-54,112
Closed -$1.08M
CVET
872
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-547,953
Closed -$11.4M
GBT
873
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-360,956
Closed -$24.6M
HNGR
874
DELISTED
Hanger Inc.
HNGR
– –
-173,389
Closed -$3.25M
DRE
875
DELISTED
Duke Realty Corp.
DRE
– –
-31,636
Closed -$1.52M
32 33 34
35
36

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.